Chiron has acquired exclusive worldwide development and commercialization rights to aerosolized cyclosporine (AcsA), an agent with potential in lung transplant acute rejection from Novartis.
Clinical studies have been conducted in about 100 lung transplant patients at the University of Pittsburgh.
Terms of agreement were not disclosed. Chiron Corporation, headquartered in Emeryville, California, has a strategic focus on cancer and infectious disease and commercializes its products through three business units: biopharmaceuticals, vaccines and blood testing.
Online Dragon Pharma Steroids
Dragon Pharma is specialized in the manufacturing of generic steroid gear Trenbolone 200 On-Line.